Panel Discussion: Overcoming Barriers to Market Access with Strategic Partnership Selection to Expedite Global Development & Commercialization
Time: 12:00 pm
day: Conference Day 1 AM
Details:
- How to create an alignment between policy makers, pharma companies, and diagnostic providers to form strategic alliances empowered to tackle regional and global regulation and reimbursement differences to ensure patients equal access to testing and precision therapies
- How can key stakeholders strategically work together to bridge the gap between assays registered in the US and local solutions to overcome the need for increased samples and additional validation to avoid delays?
- Bringing your drugs to markets outside of APAC: Identifying the right market strategy and managing local and global stakeholders to ensure success
- Strategies to achieve strategic partnerships earlier to avoid clinical trial delays
- Working towards a consortia in APAC to allow sharing of data therefore expediting approvals
- How to identify the best labs to perform testing
- What are optimal partnership designs, and what considerations should you have for partners?
